(Q44230093)

English

One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Helicobacter pylori

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

author name string

Hung WK

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Wong WM

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Wong GS

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Yip AW

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Szeto ML

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Lai KC

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Hu WH

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Chan CK

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Xia HH

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Yuen MF

10

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Fung FM

11

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Tong TS

12

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ho VY

13

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Lam SK

14

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Wong BC

15

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

2067-2072

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

An evaluation of invasive and non-invasive tests for the diagnosis of Helicobacter pylori infection in Chinese

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

Impairment of cytochrome P-450-dependent liver activity in cirrhotic patients with Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

13C-urea breath test without a test meal is highly accurate for the detection of Helicobacter pylori infection in Chinese

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

In vitro synergy between ranitidine bismuth citrate and tetracycline or clarithromycin against resistant strains of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

Intrahepatic modulation of portal pressure and its role in portal hypertension. Role of nitric oxide

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01384.X

21 January 2018

Identifiers

10.1046/J.1365-2036.2002.01384.X

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44230093&oldid=2108775335"